Moreover, the recurrence-free rate of HCC patients with PD-1-positive expressions was significantly lower than that of PD-1-negative expressions in the early stage of recurrence (1 year) (see Figure 7b). Here, PDCD1 is linked to hepatocellular carcinoma.